GLOSSARY

Supplement Bioavailability describes the extent and rate at which a relevant ingredient becomes available to the body or target, under a specified definition.

Absorption, distribution, metabolism and elimination determine how an ingredient reaches circulation and tissues. Plasma concentration does not directly establish muscle uptake or a useful performance effect. Half-life describes a concentration decline under defined conditions, while time to peak describes when a measured maximum occurs. Food, formulation, repeated use and individual physiology affect these processes. A faster or larger blood peak is therefore not automatically evidence that a formulation is better for the athlete's intended task.

The dose refers to the amount of the relevant active ingredient, not necessarily the mass of powder or the number of scoops. A single dose, daily total and body-mass-relative dose describe different quantities. Larger amounts can increase adverse effects without improving performance. Loading, maintenance and acute timing are ingredient-specific strategies rather than universal rules. Check all products used together so that repeated ingredients do not create an unintended total intake.

Apparent individual responses combine biological variation, measurement error, expectations and changes in training or diet. A person classified as a nonresponder after one noisy test may not have a stable absence of benefit. Use repeated, relevant observations under comparable conditions and consider starting nutrient status or habitual intake. Genetic mechanisms can be informative without making a commercial genetic test a validated prescription. Individualization should improve a practical decision, not turn uncertain differences into permanent athlete labels.